By Denny Jacob Y-mAbs Therapeutics' investigational new drug application for CD38-SADA was cleared by the Food and Drug Administration. The commercial-stage.
By Denny Jacob Y-mAbs Therapeutics investigational new drug application for CD38-SADA was cleared by the Food and Drug Administration. The commercial-stage biopharmaceutical company said.